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Background: Although recent advances in knee osteoarthritis (OA) treatment and evaluation were achieved, to the
best of our knowledge, few studies have evaluated the longitudinal effect of therapeutic modalities on the
functional exercise capacity of patients with knee OA. The purpose was to investigate the effects of kinesiotherapy
and electrotherapy on functional exercise capacity, evaluated using the six-minute walk test (6-MWT) in patients
with bilateral knee OA. Secondary measurements included range of motion (ROM), severity of knee pain (VAS), and
a measure of perceived health and physical function, evaluated using the Western Ontario and McMaster
Universities (WOMAC) Osteoarthritis Index.
Methods: A total of 40 women with bilateral knee OA were assigned to three groups: kinesiotherapy (KIN, n= 16),
transcutaneous electrical nerve stimulation (TENS, n= 12), or ultrasound (US, n= 10). The groups underwent
12 weeks of intervention twice per week. The participants were subjected to the 6-MWT, ROM, VAS and WOMAC
index. These tests were performed before and after the intervention. The study was focused on outpatients and
was carried out at Universidade Estadual de Campinas, Brazil.
Results: At follow-up, the KIN and US groups had significantly higher 6-MWT distances (19.8 ± 21.7 and 14.1
± 22.5%, respectively) compared with their respective pre-intervention values. All treatments were effective for
reducing pain and improving the WOMAC index.
Conclusions: We demonstrated that the 6-MWT is a tool that can be used to evaluate improvements in the
functional exercise capacity of patients submitted to a clinical intervention.
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Osteoarthritis (OA) is a chronic and degenerative joint
disease and is considered one of the most common mus-
culoskeletal disorders [1,2]. Approximately 85% of the
population near 65 years of age present radiographic evi-
dences of OA [3]. The knees, hands, hips, spine, and feet
include the joints most often affected by OA [4-6]. The
main clinical symptoms related by patients with knee
OA include pain, articular stiffness, crepitation, articular* Correspondence: andre.claudio@gmail.com
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reproduction in any medium, provided the oredema, joint deformities, articular instability, decrease in
range of motion (ROM), physical activity limitations and
muscle weakness [6,7]. For these reasons, several
pharmacologic [8,9] and non-pharmacologic strategies
[10-13] have been studied for relief of knee pain.
Physiotherapy is one of the professions that provide ef-
fective non-pharmacological interventions for people
with knee OA [14] and procedures prescribed by phy-
siotherapists are considered important and play a funda-
mental role in patient treatment. In this context,
kinesiotherapy (KIN), which comprises different types of
therapeutic exercises, such as stretching, strengthening
(isotonic, isokinetic, and isometric) and aerobic exercise,
[15] and electrotherapy are frequently used for theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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The most common types of electrotherapy are ultra-
sound (US), a modality of treatment that uses sound
waves to generate heat within a body part, and transcu-
taneous electrical nerve stimulation (TENS), a method
of pain relief in which a special device transmits low-
voltage electrical impulses through electrodes on the
skin to an area of the body that is in pain [4].
Despite recent advances in OA treatment, few studies
have evaluated the longitudinal effect of therapeutic mo-
dalities on the functional capacity of patients with knee
OA, especially that functional capacity related to exer-
cise performance. Lin et al. [19] described the results of
a battery of physical function tests used to assess the
physical function of older patients with clinical knee
and/or hip OA. These tests included: walk a distance of
8 feet, ascend/descend 4 stairs, and stand and sit on a
chair 5 times. The authors stated that these physical
function tests are safe, practical, and may be useful in
the evaluation of therapeutic interventions. French et al.
[20] compared the responsiveness of three physical per-
formance measures of function following physiotherapy
for OA of the knee and found that the 6-min walk test
(6-MWT) was more responsive in the assessment of
physical performance than the timed-up-and-go test and
the timed-stand test. In this context, the 6-MWT is a
simple, safe and low-cost field test often used to evaluate
chronic heart failure patients, chronic obstructive pul-
monary disease patients, and the elderly to regularly as-
sess functional exercise capacity and the effects of a
rehabilitation/exercise program [21,22].
Therefore, the primary purpose of this study was to in-
vestigate the effects of 12 weeks of kinesiotherapy and
electrotherapy on functional exercise capacity as evalu-
ated by the 6-MWT. Secondary measurements included
range of motion, severity of knee pain, and the measure
of perceived health and physical function evaluated by
the Western Ontario and McMaster Universities
(WOMAC) Osteoarthritis Index [23,24].Table 1 Characteristics of the subjects
KIN (n= 16)
Age (yr) 59.6 ± 7.2
(48 – 70)
Height (cm) 154.6 ± 6.1
(146.0 – 166.0)
Body mass (kg) 71.1 ± 10.8
(48.0 – 92.0)
Years diagnosed with osteoarthritis 5.6 ± 5.6
(0.08 – 15)
Data expressed as mean ± S.D. (min – max).Methods
Participants
Patients with knee OA were recruited from a Rheuma-
tology Clinic. These patients were initially contacted,
evaluated, and informed about the objective and experi-
mental procedures of the study. Of the 48 patients ini-
tially recruited, 40 patients completed all experimental
procedures. Exclusion criteria included any rheumatic
disease (with the exception of bilateral knee OA), unilat-
eral knee OA, neurological disorders, cognitive limita-
tions or history of cardiovascular, pulmonary or
endocrinology disease. Inclusion criteria included female
gender, a minimum of 45 years old, free from any other
lower limb disease (except bilateral knee OA), able to
perform physical exercise, not currently receiving phys-
ical therapy treatments for the knee OA condition,
medication compliance (all patients were taking gluco-
corticoids at the time of study), and diagnosis of bilateral
knee OA according to the American College of Rheuma-
tology criteria [25]. The participants were randomly
divided into three groups: kinesiotherapy (KIN, n = 16),
transcutaneous electric nerve stimulation (TENS,
n = 12), and ultrasound (US, n = 12). These physiother-
apy interventions were performed twice per week for
12 weeks. The patient characteristics are presented in
Table 1.
Experimental design
The study was organized in four successive phases: a
basal medical and physical examination, the pre-
intervention evaluations, the treatment period, and the
post-intervention evaluations. The basal medical exam-
ination was performed three days before the beginning
of the treatment period. The participants underwent a
detailed medical examination (performed by a rheuma-
tologist) and OA diagnostic evaluation (based on symp-
toms and conventional standing antero-posterior knee
radiographs). In the two days before and after the treat-
ment intervention, all of the participants performedExperimental groups
TENS (n = 12) US (n= 12)
64.8 ± 7.0 62.8 ± 7.6
(50 – 74) (51 – 77)
153.4 ± 6.8 153.8 ± 6.0
(143.0 – 165.0) (141.0 – 163.0)
73.9 ± 13.7 71.3 ± 10.0
(58.0 – 112.0) (50.9 – 85.0)
5.2 ± 6.8 4.8 ± 3.4
(1 – 25) (1 – 10)
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physical function by Western Ontario and MacMaster
Universities Osteoarthritis Index (WOMAC) Question-
naire, pain by using a visual analogical scale (VAS),
ROM by using a goniometer, and functional exercise
capacity evaluated by the 6-MWT. Finally, the partici-
pants were submitted to 12 weeks of treatment interven-
tion, twice per week, on non-consecutive days.
The participants were instructed to arrive at the labora-
tory in a rested and fully hydrated state, having not con-
sumed caffeine in the previous 4 h, and to avoid strenuous
exercise in the 48 h preceding a session. To minimize the
effects of diurnal biological variation, all the tests were per-
formed at the same time of day.
All experimental procedures were approved by the
University Human Research Ethics Committee and con-
formed to the principles outlined in the Declaration of
Helsinki. All participants signed informed consent forms
prior to participating in the study.
Modes of physiotherapy treatment
The participants in each group participated in their re-
spective treatment intervention for 12 weeks (24 ses-
sions). All sessions were supervised by an experienced
physical therapist. Missed sessions were compensated
during the subsequent weeks so that the total number of
sessions was completed.
The KIN protocol consisted of supervised stretching
and isometric exercises for the entire lower limb. The
stretching exercises were performed actively, using the
static method. The participants were instructed to per-
form three bouts of 30 seconds each in each lower limb
to the following muscles and in this order: calf, quadri-
ceps, and hamstring muscles. The stretches were alter-
nated for each limb. The static stretching exercises were
performed until the maximal range of motion or pain
threshold was reached. The isometric exercises consisted
of three exercises using a conventional plastic ball
(diameter of 20 cm) and one exercise using an elastic
band (Rubber Band, Orange Color, Carci, Brazil) with
extra strong resistance measuring 1.50 x 0.14 m. The
participants were instructed to perform a total of 30
repetitions. Each repetition lasted 6 seconds with an
interval of approximately 3 seconds. In the first exercise
using the ball, the patients were placed in a supine pos-
ition with knees flexed. The ball was positioned between
the patient’s knees, and the patient was instructed to
press the knees against the ball to perform a maximal
contraction. This exercise aimed to strengthen the ad-
ductor muscles. In the second exercise using the ball,
the patients were placed in a supine position with one
knee flexed and the other knee in full extension. With
the ball placed under the ankle of the limb that
was extended, the participants performed a maximalcontraction against the ball. The patient alternated per-
forming the exercise for each lower limb, and this exer-
cise aimed to strengthen the quadriceps muscles. In the
third exercise using the ball, the patient was positioned
prone with both knees extended. The ball was placed
under one ankle, and the patient was instructed to per-
form a maximal contraction against the ball. The patient
alternated performing the exercise for each lower limb,
and this exercise aimed to strengthen the hamstring
muscles. Finally, in the fourth exercise, the patients were
placed in a supine position with knees flexed. The knees
were tied with an elastic band, and the patients were
requested to perform a maximal abduction movement of
the lower limbs. This exercise aimed to strengthen the
abductor muscles. Each session lasted approximately
20 minutes.
The TENS was delivered by a transcutaneous electrical
stimulator (Neurodyn II, Ibramed, Brazil) with two chan-
nels and four square, self-adhesive percutaneous electro-
des measuring 5 x 5 cm. The TENS was applied using a
frequency of 100 Hz, pulse width of 50 μs, intensity
(mA) set at the individual subject's sensorial threshold,
modulation up to 50% of variation frequency, quadratic
biphasic symmetrical pulse and a length of application
of 20 minutes. In the TENS protocol, the participants
were stimulated in dorsal decubitus, adequately posi-
tioned with a roll under their knees. The percutaneous
electrodes for the electrical stimulation were placed on
the anterior medial and lateral portions of the knee. This
group also performed the same stretching and isometric
exercises for the lower limbs described for the KIN
group. Each session lasted approximately 40 minutes.
The US protocol consisted of continuous ultrasonic
waves of 1 MHz frequency and 0.8 W/cm [2] power, ap-
plied with a 5-cm diameter applicator (Sonic, 1–3 MHz,
HTM, Brazil). The patients were placed in a supine pos-
ition, and an acoustic gel that did not contain any
pharmacologically active substance was applied. Ultra-
sound was then applied to the medial and lateral parts
of the knee in circular movements with the probe at
right angles to ensure maximum absorption of the en-
ergy. Each session lasted 3–4 minutes, depending on the
knee size due to edema. During the evaluation, we
observed that some subjects exhibited evidence of
edema. This group also performed the same stretching
and isometric exercises for the lower limbs described for
the KIN group. Each session lasted approximately
25 minutes.
Assessments
The participants were assessed at baseline and at the
end of the treatment by an investigator who was blind to
the randomization. The following assessments were per-
formed: severity of pain, ROM for extension and flexion
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physical function.
Severity of knee pain
Knee pain was assessed using a VAS. The VAS consists
of a 10-cm line, with the left extreme indicating “no
pain” or zero and the right extreme indicating “unbear-
able pain” or 10. The participants were asked to use the
scale to indicate their current level of pain. Higher
values suggest more intense pain. The values (in centi-
meters) were recorded for the statistical analysis.
Range of motion (ROM)
Knee flexion and extension ROM in degrees were mea-
sured bilaterally in a supine position according to Nor-
kin and White [26]. To this end, the lateral femoral
condyle was used as a landmark for the measurement of
knee flexion and extension. The central pivot of a uni-
versal goniometer (CARCI, São Paulo, Brazil) was placed
over the midpoint of the lateral joint margin, with the
stationary arm of the universal goniometer aligned with
the great trochanter. The moving arm of the goniometer
was then aligned with the lateral malleolus with the neu-
tral position taken as zero. For the knee flexion meas-
urement, initially the hip was at zero degrees of
extension, abduction, and adduction, but as the patients
maximally flexed the knee, the hip also flexed. Thus, the
examiner supported the lower limb and stabilized the
femur to prevent rotation, abduction, and adduction of
the hip. For the knee extension, the measurement was
made with the lower limb extended. The previous pre-
cautions to prevent compensations (i.e., adduction, ab-
duction, and rotation) were taken. The measurements
were performed by two experienced physical therapists.
Each knee and position (flexion or extension) was mea-
sured twice, and the higher angle was recorded for the
statistical analysis.
The six-minute walking test (6-MWT)
The 6-MWT was performed to evaluate functional exer-
cise capacity in a 100 m-long indoor hallway free of
obstacles. The length of the corridor was marked every
1 m. The participants were instructed to walk at a self-
selected regular pace to cover as much distance as they
could during the allotted time. If necessary, slowing
down and stopping to rest were allowed. At the end of
each minute, the participants were given feedback on
the elapsed time and standardized encouragement in the
form of statements such as “you are doing well, keep it
up” and “do your best.” These technical aspects are in
line with the American Thoracic Society recommenda-
tions for the 6-MWT [27]. The distance covered (in
meters) was used for the statistical analysis. The test-
retest reliability of the 6-MWT has been ascertained inpatients with knee OA [28]. During the test, all the par-
ticipants walked independently without using walking
aids.
WOMAC Osteoarthritis Index
A disease-specific index of disability, the WOMAC
Osteoarthritis Index, was used as a subjective measure
of perceived health and physical function. The WOMAC
Osteoarthritis Index is a three-part questionnaire that
can be completed by the subject in approximately
10 minutes, consists of 24 questions and probes clinic-
ally important symptoms in the areas of pain (5 ques-
tions), stiffness (2 questions), and physical function
(17 questions) for patients with OA of the hip and/or
knee [23,24]. In the present study, we used a Likert scale
version of the WOMAC that allows patients to make
their responses on a five-point scale (0 = none, 1 =mild,
2 =moderate, 3 = severe, 4 = extreme). The higher the
score achieved, the lower the level of perceived health
and physical function. Scores were generated for the
three dimensions of pain, stiffness and physical function
by summing the coded responses. The patient should
answer the questions to best describe their symptoms
and difficulties from the past 72 hours [29]. Psychomet-
ric studies have shown moderate to high validity and re-
liability for the WOMAC questionnaire [30].
Statistical analysis
STATISTICA v 7.0 for Windows was used for the statis-
tical analyses. All the variables presented normal distri-
butions according to Kolmogorov-Smirnov tests. Two-
way repeated-measure analyses of variance (ANOVA)
were used to assess group (KIN vs. TENS vs. US) and
time (before vs. after) differences in the variables mea-
sured. When significant group-by-time interactions were
present, Tukey’s post hoc procedures were used to iden-
tify the specific differences.
To describe the differences in related treatments, the
effect sizes were calculated as the difference between the
means divided by the pooled standard deviation. On the
basis of Cohen’s criteria (29), an effect size of ≥0.20 and
<0.50 was considered small, ≥0.50 and <0.80 medium,
and ≥0.80 large.
All the data are presented as the mean ± standard de-
viation (SD) (min – max). The results were determined
to be statistically significant at p < 0.05.
Results
All the participants completed 24 treatment sessions.
Table 2 presents the data with respect to the evaluation
of right and left knee joint pain by VAS (cm) of the KIN,
TENS and US groups. No significant differences were
observed between the groups before the treatment
period for the right and left knee (mean for all groups:
Table 2 Visual analog score (in centimeter) for both knees in each group before and after treatment
Right Knee Left Knee
Before After P Effect size Before After P Effect size
KIN (n = 16) 6.9 ± 1.9 (5.0 – 10.0) 2.3 ± 2.7a (0.0 – 8.0) 0.0001 0.70 7.0 ± 2.1 (4.0 – 10.0) 2.4 ± 2.8a (0.0 – 7.0) 0.0008 0.68
TENS (n = 12) 8.0 ± 1.5 (6.0 – 10.0) 2.6 ± 2.9a (0.0 – 7.5) 0.0001 0.76 5.6 ± 2.7 (0.0 – 10.0) 2.3 ± 2.5a (0.0 – 9.0) 0.004 0.53
US (n = 12) 6.6 ± 3.0 (0.0 – 10.0) 4.5 ± 3.7a (0.0 – 10.0) 0.009 0.41 7.3 ± 2.3 (4.0 – 10.0) 3.8 ± 3.1 (0.0 – 7.0) 0.054 0.54
Data expressed as mean ± S.D. (min – max).
a different from before for the same group.
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between the different types of treatment. However, in
the intra-group comparisons (before vs. after) a signifi-
cant decrease was observed in the VAS for pain in all ex-
perimental groups and for both knees except for the left
knee in the US group. No significant differences were
observed between the groups for the right and left knee
after the treatment period.
The data obtained from the evaluation of knee ROM
are presented in Table 3. No significant differences were
observed between the groups before the treatment
period for the right and left knee in flexion and exten-
sion thus, there is no superiority in comparison between
the different types of treatment. The protocols adopted
by the present study did not cause improvements in
flexion for either knee. For extension, increases in ROM
were found in the KIN and TENS groups for both knees.
The WOMAC total scores and the score for each di-
mension were similar in all three groups at baseline ex-
cept for the KIN group when compared with the US
group (Table 4). Compared with the baseline, significant
improvements were observed in each group at the end
of the treatment. The improvement in the patients trea-
ted with US was significantly less pronounced than that
in the patients from the KIN and TENS groups
(p < 0.05).
The 6-MWT was completed by all the subjects with-
out premature cessation and/or breaks. No symptoms or
clinical complications occurred during the tests. The 6-
MWT performances of the participants are shown in
Table 5. No statistically significant differences betweenTable 3 Range of motion (in degrees) for both knees in each
Flexion
Right Left
Before After P Before After P
KIN 76 ± 9 73± 12 >0.77 74 ± 11 69 ± 12 >0.98
(n = 16) (56 – 90) (55 – 90) (50 – 90) (55 – 87)
TENS 79 ± 7 76± 10 >0.34 81 ± 12 79 ± 7 >0.44
(n = 12) (68 – 90) (59 – 90) (50 – 90) (65 – 89)
US 81 ± 8 76± 7 >0.83 80 ± 8 75± 8 >0.39
(n = 12) (67 – 90) (66 – 87) (67 – 90) (56 – 86)
Data are expressed as mean ± S.D (min – max).
a different from before for the same group.the groups were found at baseline. The distances com-
pleted and the walking speeds were significantly higher
in the KIN (19.8%) and US (14.1%) groups when com-
pared to the pre-treatment values. No statistically signifi-
cant difference was found in the TENS group (8.9%). No
statistically significant differences between the groups
were found after the treatment period.Discussion
Knee OA is expected to be the fourth highest cause of
disability in women and is responsible for the deterior-
ation of quality of life and functional capacity [31]. A
plethora of studies have investigated several aspects
related to muscle function, such as strength [32] and
aerobic capacity [33] as well as other clinical aspects
such as pain [34], stiffness [35], ROM [36] and
WOMAC index [37] in patients with OA. Despite these
important advances, to our knowledge, few studies have
investigated the effects of different types of non-
pharmacological treatments on the functional exercise
capacity of patients with OA. In this context, the 6-
MWT is an excellent tool to evaluate the effect of ther-
apy on the functional exercise capacity. In this study, we
found that the KIN and US procedures improved the
functional exercise capacity of patients with bilateral
knee OA after the intervention period; however, we
found no inter-group differences. Moreover, we also
evaluated the effect of the treatment period on pain
using the VAS and WOMAC index, and we found that
the three interventions improved the pain. Thegroup before and after treatment
Extension
Right Left
Before After P Before After P
171± 6 177± 4a 0.0003 172± 5 178± 3a 0.001
(160 – 180) (168 – 180) (161–180) (170 – 180)
172± 6 178± 3a 0.003 170± 8 176± 4a 0.002
(160 – 180) (170 – 180) (150 – 180) (168 – 180)
171± 6 175± 7 0.21 172± 7 173± 7 0.47
(165 – 180) (156 – 180) (160 – 180) (160 – 180)
Table 4 Scores for the WOMAC Index in each group before and after treatment
Pain Rigidity Physical function Total score
Before After P Before After P Before After P Before After P Effect
size
KIN
(n = 16)
8.9 ± 4.4
(1 – 18)
2.0 ± 2.3a
(0 – 8)
0.0001 3.0 ± 2.1
(0 – 6)
0.4 ± 0.8a
(0 – 2)
0.0001 25.6 ± 13.6b
(6 – 48)
4.6 ± 5.9ab
(0 – 21)
0.0001 37.5 ± 18.7b
(7 – 69)
7.0 ± 8.1ab
(0 – 28)
0.0001 0.73
TENS
(n = 12)
10.7 ± 3.0
(4 – 15)
3.3 ± 2.9a
(0 – 9)
0.0001 4.3 ± 1.9
(2 – 8)
0.8 ± 0.8a
(0 – 2)
0.0001 31.8 ± 9.2
(16 – 50)
10.1 ± 8.3ab
(0 – 25)
0.0001 46.8 ± 12.2
(22 – 69)
14.2 ± 11.0ab
(0 – 35)
0.0001 0.81
US
(n = 12)
10.1 ± 3.8
(4 – 16)
6.2 ± 4.2a
(2 – 17)
0.01 4.4 ± 2.5
(0 – 8)
2.0 ± 1.9a
(0 – 6)
0.004 38.3 ± 9.1
(22 – 51)
20.6 ± 9.8a
(5 – 43)
0.0001 53.5 ± 12.2
(36 – 70)
28.8 ± 14.8a
(8 – 66)
0.0002 0.67
Data are expressed as mean ± S.D. (min – max).
a different from before for the same group.
b different from US group at same time point.
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neous because we recruited only women with bilateral
knee OA.
Pain is one of the most common complaints and dis-
abling symptoms in OA populations. In the present
study, we evaluated the efficacy of different treatment
modes on knee pain, measured using the VAS and the
pain dimension of the WOMAC index. We found that
pain in both knees decreased in all the experimental
groups. This is not the first study to demonstrate the
positive effects of non-pharmacologic management on
knee pain in OA patients. The Cochrane group [38] sys-
tematically reviewed and combined the study results of
17 OA exercise studies (a total of 2562 participants).
This group found that land-based exercise had a small-
to-moderate beneficial effect on pain for people with
symptomatic knee OA. Roddy et al. [39] reviewed 19
randomized clinical trials investigating the effects of
land-based exercise for knee or hip OA. They concluded
that both strengthening and aerobic exercises performed
on land could reduce pain and improve the function and
health status in patients with knee and hip OA. How-
ever, these authors stated that there was not enough evi-
dence to support or recommend specific types of
exercise.
Concerning the TENS, Rutjes et al. [5] conducted a
systematic Cochrane review of transcutaneous electrosti-
mulation vs. sham or no specific intervention on pain in
individuals with knee OA. This systematic review foundTable 5 Distance covered and percent change obtained in the
Before After
KIN (n = 16) 333 ± 80 387 ± 59a
(212 – 500) (308 – 500)
TENS (n = 12) 330 ± 61 355 ± 65
(200 – 420) (275 – 500)
US (n = 12) 318 ± 68 358 ± 77a
(200 – 400) (200 – 450)
Data are expressed as mean ± S.D. (min – max).
a different from before for the same group. N/A: not applicable.little evidence of a significant effect for electrostimula-
tion compared to sham or no intervention on pain in
knee OA. The authors attributed these results to the
poor quality of the trials and the high degree of hetero-
geneity across the studies. Our results contradict this
systematic review because we found an improvement in
the pain index (VAS and pain dimension of the
WOMAC index) in all the experimental groups. To
evaluate the therapeutic effect of the TENS modalities,
NG et al. [40] studied 24 patients and compared electro-
acupuncture treatment and TENS, using the same para-
meters for both (low frequency - 2 Hz, continuous
mode, pulsation of 200 μs for 20 min of application, and
a control group with only educational orientations on
OA of the knee) and showed that either electroacupunc-
ture treatment or TENS are effective in pain reduction
because a prolonged analgesic effect was maintained in
the two groups. Another study was performed with 62
patients between 50 and 75 years of age and presenting
knee OA during a four-week period. These patients were
divided into four treatment groups: TENS placebo
group, TENS group, exercise group and TENS plus exer-
cise group. The results showed no significance between
the different types of treatment due to the protocol dur-
ation [41]. This treatment was similar to ours in the
number of patients and the modalities used, such as the
conventional TENS and the isometric exercises. How-
ever, the TENS parameters and the application time
were different and, unlike our study, did not presentsix-minute walk test before and after treatment
Δ% P Effect size
19.8 ± 21.7 0.003 −0.35
(−6.1 – 74.5)
8.9 ± 17.1 0.61 N/A
(−22.9 – 37.5)
14.1 ± 22.5 0.04 −0.26
(−6.3 – 80.0)
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duration. In our study, the three groups (KIN, TENS and
US) showed significant differences after the treatment
duration.
In regards to the US, Loyola-Sanchez et al. [42] con-
ducted a meta-analysis of the efficacy of US for decreas-
ing pain and improving physical function in people with
knee OA. New evidence was found that shows that US
can reduce pain by 21% compared to a control group.
Range of motion was another variable evaluated in the
present study. We did not observe any difference due to
the three modes of treatment used in this study. Our
results agree with Tascioglu et al. [43] who compared
the effectiveness of ultrasound (continuous versus
pulsed) therapy versus placebo ultrasound in patients
with knee OA and also found no differences in ROM.
These authors also found improvements in the
WOMAC index and functional capacity as evaluated by
a 20-m walking test.
Finally, we were particular interested in evaluating the
effect of KIN, US and TENS treatment on the 6-MWT
performance of woman with bilateral knee OA. Several
modalities are available for the objective evaluation of
cardiorespiratory fitness. Some provide a very complete
assessment of all the systems involved in exercise per-
formance, whereas others provide basic information but
are low-tech and easy to perform. The 6-MWT is a sim-
ple test that requires a hallway but no equipment or
advanced training for the technicians. This test evaluates
the global and integrated responses of all the systems
involved during exercise, including the pulmonary, car-
diovascular and muscular systems [22]. To help predict
the total distance walked during the 6-MWT, Enright
and Sherrill [44] established a reference equation that
incorporates subject characteristics such as age, body
mass and height. These subject characteristics were
shown to be associated with the distance walked during
the 6-MWT. When applying this reference equation to
the current data, the results revealed that the KIN, US
and TENS groups walked 74%, 79% and 85%, respect-
ively, of the predicted values found by the Enright and
Sherrill [44] equation in the pre-evaluation. These mod-
est values demonstrate the low functional exercise cap-
acity, and consequently low health status, of the patients
evaluated in the present study. On average, our patients
walked 328.8 m before the treatment. These values agree
with Wang et al. [45] who compared the efficacy of
aquatic exercises and land-based exercises for patients
with knee OA. However, these values are lower than
those reported by French et al. [20] (405.1 m). The dif-
ference most likely results from the poorer physical con-
dition of our volunteers, as represented in the lower
highest total score obtained for the WOMAC index
compared with that in the study by French et al. [20]Additionally, the sample studied by French et al. [20]
contained male participants with unilateral and bilateral
knee OA. The difference in this study is that our sample
is homogeneous because we recruited only women with
bilateral knee OA.
The impact of health status on 6-MWT performance
was investigated in 165 elderly people. The covered dis-
tance decreased significantly with increasing age and
with worsening health status (corrected for age) [46].
Patients with dilated cardiomyopathy were also investi-
gated, and the results demonstrated that the covered dis-
tance and peak oxygen uptake (cardiorespiratory fitness
index) were closely correlated [47]. In addition, the
authors found a correlation between the 6-MWT cov-
ered distance and the New York Heart Association func-
tional class. Santana et al. [21] showed that in the
healthy elderly, the 6-MWT can be used to evaluate
improvements in functional exercise capacity after exer-
cise training. However, the 6-MWT is not appropriate to
evaluate improvements in the cardiorespiratory fitness
of elderly healthy men who have undergone exercise
training because this test lacks sufficient sensitivity. Par-
ticularly in OA, French et al. [20] studied the responsive-
ness of three physical performance measures of function
following physiotherapy for knee OA and found that the
6-MWT was more responsive for the assessment of
physical performance than the timed-up-and-go test and
the timed-stand test.
Following 12 weeks of treatment procedures per-
formed by the KIN and US groups, the distance covered
in the 6-MWT increased by 19.8% and 14.1%, respect-
ively. These improvements in functional exercise cap-
acity indicate improvements in muscle strength and
aerobic metabolism assuming that patients with knee
OA are often physically deconditioned, interventions, as
performed by current study, potentiate those muscle
adaptations. Wang et al. [45] investigated the effects of
aquatic exercises and land-based exercises for patients
with knee OA and found that the 6-MWT performance
increased by 19 ± 7% and 12 ± 5%, respectively. These
changes were similar to the results found in previous
studies [45,48]. Although these articles have studied dif-
ferent treatment modes, the results presented here sug-
gest an improvement in functional exercise capacity and,
consequently, of the quality of life and ability to perform
activities of daily living. In fact, this assertion is sup-
ported by the positive results on the WOMAC and VAS
scores. This improvement in ability to perform physical
effort is very important because physical exercise is con-
sidered a valuable tool to reduce the risk of cardiovascu-
lar and endocrine diseases and to improve bone and
muscle conditioning. These medical conditions may
affect patients with OA due to the high level of inactivity
and body disuse found in these patients. Indeed, this
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reduced aerobic capacity in patients with severe hip and
knee OA compared to controls [49,50].
Study limitations
We assessed study outcomes only on pre- and post-tests,
so we were not able to determine the outcomes of these
interventions across time. The evaluation of parameters
related to exercise physiology, such as the maximal oxy-
gen uptake, economy of motion and anaerobic threshold,
could provide additional information on the level of aer-
obic fitness of the subjects before and after the treat-
ment period.
Conclusions
Many previous studies have compared one treatment
protocol group with one control group and have con-
cluded that the treatment made a difference, but there is
no indication of how one program compares with other
treatment protocols. Our study compared three popular
non-pharmacological treatments. The main finding of
this study was that the 6-MWT is a tool that can be
used to evaluate improvements in the functional exercise
capacity of patients submitted to a clinical intervention.
Furthermore, the study results showed that KIN, TENS
and US are effective for reducing pain and improving
the WOMAC score and that KIN and US are effective
for increasing the 6-MWT performance. Together, these
results can be informative for both clinicians and
patients with OA in selecting appropriate types of treat-
ment based on their preferences and convenience.
The results of this study provide further evidence that
patients with knee OA can achieve significant benefits
from using KIN, TENS or US therapeutic procedures.
The knowledge of function and disability for patients
with knee OA, obtained through use of the 6-MWT,
may help clinicians and physical therapists evaluate and
develop rehabilitation programs to improve functional
efficiency and capability for this population.
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